搜索





搜索





Lyell Immunopharma Inc

LYEL

添加自选

10.120USD

-0.410-3.89%

收盘 09-24 16:00（美东）

236.10M总市值

亏损市盈率 TTM

Lyell Immunopharma Inc

10.120

-0.410-3.89%

财务摘要利润表资产负债表现金流量表财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表财报公司估值风险评估

LYEL 利润表

您可以在这里找到Lyell Immunopharma Inc的年度或季度收入报告，以深入了解Lyell Immunopharma Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

营业总收入

-50.00%4.00K

-71.43%2.00K

-45.45%6.00K

-55.88%15.00K

-38.46%8.00K

133.33%7.00K

-15.38%11.00K

36.00%34.00K

-51.85%13.00K

-95.38%3.00K

-99.97%13.00K

733.33%25.00K

-99.92%27.00K

-88.25%65.00K

1614.60%48.39M

-99.89%3.00K

1260.01%35.74M

-77.38%553.00K

22.06%2.82M

157.48%2.75M

-15.72%2.63M

94.67%2.44M

--2.31M

--1.07M

--3.12M

--1.26M

营业收入

-50.00%4.00K

-71.43%2.00K

-45.45%6.00K

-55.88%15.00K

-38.46%8.00K

133.33%7.00K

-15.38%11.00K

36.00%34.00K

-51.85%13.00K

-95.38%3.00K

-99.97%13.00K

733.33%25.00K

-99.92%27.00K

-88.25%65.00K

1614.60%48.39M

-99.89%3.00K

1260.01%35.74M

-77.38%553.00K

22.06%2.82M

157.48%2.75M

-15.72%2.63M

94.67%2.44M

--2.31M

--1.07M

--3.12M

--1.26M

营业费用

6.04%47.34M

-23.02%44.26M

-2.94%61.32M

-28.02%37.27M

-15.67%44.76M

5.29%57.50M

1.40%63.17M

-12.34%51.77M

-19.50%53.08M

-15.11%54.61M

-11.60%62.30M

-7.71%59.06M

-5.02%65.93M

-11.85%64.33M

39.95%70.48M

23.27%64.00M

6.24%69.42M

26.23%72.98M

20.37%50.36M

36.93%51.92M

-38.18%65.33M

68.75%57.81M

--41.84M

--37.91M

--105.68M

--34.26M

研发费用

13.39%39.52M

-15.99%36.60M

6.17%52.20M

-30.84%28.17M

-16.33%34.97M

3.24%43.57M

-1.23%49.16M

-7.10%40.73M

-11.95%41.80M

-8.92%42.21M

9.78%49.77M

11.96%43.85M

18.29%47.47M

16.78%46.34M

135.10%45.34M

24.60%39.17M

-13.59%40.13M

-4.45%39.68M

-45.04%19.29M

28.29%31.43M

-52.19%46.45M

62.86%41.53M

--35.09M

--24.50M

--97.15M

--25.50M

折旧摊销及损耗

-29.12%2.22M

-32.23%2.33M

-52.31%2.40M

-45.17%2.57M

-36.03%3.13M

-31.51%3.44M

-0.61%5.03M

-8.31%4.68M

-3.18%4.90M

-0.06%5.02M

0.32%5.06M

10.45%5.10M

21.36%5.06M

20.06%5.03M

10.43%5.04M

12.96%4.62M

38.57%4.17M

113.84%4.19M

214.39%4.56M

270.56%4.09M

212.89%3.01M

152.32%1.96M

--1.45M

--1.10M

--962.00K

--776.00K

其他营业费用

---1.76M

-1493.28%-1.90M

-191.81%-1.50M

-117.95%-1.59M

----

89.08%-119.00K

19.97%-513.00K

-150.00%-730.00K

-71.53%-976.00K

15.37%-1.09M

47.02%-641.00K

76.66%-292.00K

51.41%-569.00K

-14.80%-1.29M

-51.63%-1.21M

-65.04%-1.25M

-425.11%-1.17M

-105.87%-1.12M

90.18%-798.00K

-379.75%-758.00K

78.35%-223.00K

-354.17%-545.00K

---8.12M

---158.00K

---1.03M

---120.00K

营业利润

-6.05%-47.34M

23.01%-44.26M

2.93%-61.31M

28.00%-37.25M

15.67%-44.75M

-5.28%-57.49M

-1.40%-63.16M

12.36%-51.74M

19.48%-53.06M

15.03%-54.61M

-181.96%-62.29M

7.75%-59.04M

-95.71%-65.91M

11.27%-64.26M

53.53%-22.09M

-30.18%-64.00M

46.30%-33.67M

-30.81%-72.43M

-20.28%-47.54M

-33.43%-49.16M

38.86%-62.71M

-67.77%-55.37M

---39.52M

---36.84M

---102.57M

---33.00M

净非营业利息收入（费用）

利息收入

-33.33%2.18M

-43.19%2.19M

-45.61%2.68M

-45.25%3.27M

-48.52%3.28M

-43.36%3.86M

-30.55%4.92M

-9.73%5.96M

20.90%6.36M

51.63%6.82M

105.15%7.08M

193.56%6.61M

452.94%5.26M

1032.75%4.50M

969.04%3.45M

733.70%2.25M

336.70%952.00K

12.15%397.00K

-47.99%323.00K

-75.36%270.00K

-88.41%218.00K

-84.88%354.00K

--621.00K

--1.10M

--1.88M

--2.34M

特殊收入（费用）

185.78%398.00K

14231.20%17.91M

40.50%-82.10M

-493.44%-4.86M

-186.46%-1.33M

100.89%125.00K

-5063.49%-137.99M

--1.23M

152.55%1.54M

-68.46%-13.97M

-61.95%2.78M

100.00%0.00

18.83%-2.92M

-313.77%-8.29M

120.05%7.31M

---8.52M

---3.60M

--3.88M

---36.45M

----

其他非经营性收入（费用）

146.23%398.00K

1267.48%17.91M

-99.74%11.00K

----

118.29%118.00K

20.18%1.31M

948.22%4.29M

-102.72%-43.00K

-97.85%-645.00K

-0.91%1.09M

-117.25%-506.00K

12038.46%1.58M

---326.00K

15614.29%1.10M

6768.18%2.93M

-18.75%13.00K

----

125.93%7.00K

-195.65%-44.00K

-42.86%16.00K

-465.52%-106.00K

-101.90%-27.00K

--46.00K

--28.00K

--29.00K

--1.42M

税前利润

-4.85%-44.76M

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

所得税

----

--0.00

----

除税后利润

-4.85%-44.76M

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

持续经营利润

-4.85%-44.76M

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

归属于母公司的净利润

-4.85%-44.76M

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

归属于普通股东的净利润

-4.85%-44.76M

53.73%-24.15M

26.68%-140.72M

12.87%-38.85M

6.82%-42.68M

13.96%-52.20M

-262.62%-191.94M

12.33%-44.58M

28.30%-45.81M

9.40%-60.67M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

89.97%-8.40M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

-115.42%-83.71M

-36.83%-48.88M

37.81%-62.59M

-88.25%-55.04M

---38.86M

---35.72M

---100.66M

---29.24M

基本每股收益

33.61%-1.92

68.79%-1.10

-900.46%-6.86

-1122.52%-2.13

-1508.73%-2.89

-1382.50%-3.54

-227.46%-0.69

14.04%-0.17

29.76%-0.18

11.06%-0.24

-546.80%-0.21

28.48%-0.20

-73.15%-0.26

3.87%-0.27

90.27%-0.03

-38.81%-0.28

42.79%-0.15

-23.12%-0.28

-107.92%-0.33

-38.57%-0.20

37.81%-0.26

-88.25%-0.23

---0.16

---0.15

---0.41

---0.12

稀释每股收益

33.61%-1.92

68.79%-1.10

-900.46%-6.86

-1122.52%-2.13

-1508.73%-2.89

-1382.50%-3.54

-227.46%-0.69

14.04%-0.17

29.76%-0.18

11.06%-0.24

-546.80%-0.21

28.48%-0.20

-73.15%-0.26

3.87%-0.27

90.27%-0.03

-38.81%-0.28

42.79%-0.15

-23.12%-0.28

-107.92%-0.33

-38.57%-0.20

37.81%-0.26

-88.25%-0.23

---0.16

---0.15

---0.41

---0.12

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Lyell Immunopharma Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 LYEL 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Lyell Immunopharma Inc 财年末的营收是多少？



Lyell Immunopharma Inc 2025 财年营收为 36.00K，高于上一财年的61.00K。

Lyell Immunopharma Inc 最近一个季度的营收是多少？



Lyell Immunopharma Inc 最近一个季度的营收为 4.00K，同比增长 -50.00%。

Lyell Immunopharma Inc 全年的净利润是多少？



Lyell Immunopharma Inc 2025 财年净利润为 -274.45M。

Lyell Immunopharma Inc 上一季度的净利润是多少？



Lyell Immunopharma Inc 最近一个季度的净利润为 -44.76M。

Lyell Immunopharma Inc 年度营业利润是多少？



Lyell Immunopharma Inc 2025 财年的营业利润为 -201.63M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。